These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24700805)

  • 1. Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease.
    Guin S; Pollard C; Ru Y; Ritterson Lew C; Duex JE; Dancik G; Owens C; Spencer A; Knight S; Holemon H; Gupta S; Hansel D; Hellerstein M; Lorkiewicz P; Lane AN; Fan TW; Theodorescu D
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24700805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
    Guin S; Ru Y; Agarwal N; Lew CR; Owens C; Comi GP; Theodorescu D
    Clin Cancer Res; 2016 Mar; 22(5):1274-83. PubMed ID: 26490312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
    Oldenburg D; Ru Y; Weinhaus B; Cash S; Theodorescu D; Guin S
    BMC Cancer; 2016 Sep; 16(1):713. PubMed ID: 27595989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of glycogen debranching enzyme in bladder cancer.
    Weinhaus B; Guin S
    Biomed Rep; 2017 Jun; 6(6):595-598. PubMed ID: 28584628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice.
    Sottnik JL; Mallaredy V; Chauca-Diaz A; Ritterson Lew C; Owens C; Dancik GM; Pagliarani S; Lucchiari S; Moggio M; Ripolone M; Comi GP; Frierson HF; Clouthier D; Theodorescu D
    Carcinogenesis; 2019 Mar; 40(1):194-201. PubMed ID: 30403777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth.
    Richmond CS; Oldenburg D; Dancik G; Meier DR; Weinhaus B; Theodorescu D; Guin S
    Oncotarget; 2018 Mar; 9(24):16718-16730. PubMed ID: 29682180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.
    Cheng A; Zhang M; Gentry MS; Worby CA; Dixon JE; Saltiel AR
    Genes Dev; 2007 Oct; 21(19):2399-409. PubMed ID: 17908927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the equine glycogen debranching enzyme gene (AGL): Genomic and cDNA structure, localization, polymorphism and expression.
    Herszberg B; Mata X; Giulotto E; Decaunes P; Piras FM; Chowdhary BP; Chaffaux S; Guérin G
    Gene; 2007 Dec; 404(1-2):1-9. PubMed ID: 17905541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.
    Cheng A; Zhang M; Okubo M; Omichi K; Saltiel AR
    Hum Mol Genet; 2009 Jun; 18(11):2045-52. PubMed ID: 19299494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
    Hensel J; Duex JE; Owens C; Dancik GM; Edwards MG; Frierson HF; Theodorescu D
    Mol Cancer Res; 2015 Sep; 13(9):1306-15. PubMed ID: 26078295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5' flanking region.
    Bao Y; Dawson TL; Chen YT
    Genomics; 1996 Dec; 38(2):155-65. PubMed ID: 8954797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis in glycogen storage diseases.
    Chen YT; Bali D; Sullivan J
    Prenat Diagn; 2002 May; 22(5):357-9. PubMed ID: 12001186
    [No Abstract]   [Full Text] [Related]  

  • 13. Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.
    Abdullah IS; Teh SH; Khaidizar FD; Ngu LH; Keng WT; Yap S; Mohamed Z
    Genes Genomics; 2019 Aug; 41(8):885-893. PubMed ID: 31028654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glycogen metabolism in bladder cancer.
    Ritterson Lew C; Guin S; Theodorescu D
    Nat Rev Urol; 2015 Jul; 12(7):383-91. PubMed ID: 26032551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease.
    Chen YT; He JK; Ding JH; Brown BI
    Am J Hum Genet; 1987 Dec; 41(6):1002-15. PubMed ID: 2961257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms.
    Bao Y; Yang BZ; Dawson TL; Chen YT
    Gene; 1997 Sep; 197(1-2):389-98. PubMed ID: 9332391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId.
    Endo Y; Fateen E; El Shabrawy M; Aoyama Y; Ebara T; Murase T; Podskarbi T; Shin YS; Okubo M
    Clin Chem Lab Med; 2009; 47(10):1233-8. PubMed ID: 19754354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a Functional Recombinant Human Glycogen Debranching Enzyme (hGDE) in N. benthamiana Plants and in Hairy Root Cultures.
    Rodriguez-Hernandez M; Triggiani D; Ivison F; Demurtas OC; Illiano E; Marino C; Franconi R; Massa S
    Protein Pept Lett; 2020; 27(2):145-157. PubMed ID: 31622193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.
    Mili A; Ben Charfeddine I; Amara A; Mamaï O; Adala L; Ben Lazreg T; Bouguila J; Saad A; Limem K; Gribaa M
    Clin Genet; 2012 Dec; 82(6):534-9. PubMed ID: 22035446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.